jornal vascular brasileiro

european journal of epidemiology

[1] Rationale and Design of the Hamburg City Health Study.

[2] cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases

[3] platelets are at the nexus of vascular diseases

[4] effects of exercise on cardiovascular performance in the elderly

[5] balloons and stents in the endovascular treatment of cerebral aneurysms: vascular anatomy remodeled

[6] avaliação da doença vascular do enxerto no transplante cardíaco: experiência de um centro brasileiro assessment of cardiac allograft vasculopathy in cardiac transplantation: experience of a brazilian center

[7] curva de aprendizado em cirurgia aórtica videolaparoscópica: estudo experimental em porcos laparoscopic aortic surgery learning curve: experimental study in pigs

[8] Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

[9] Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

[10] Dilating Vascular Diseases: Pathophysiology and Clinical Aspects

[11] Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.

[12] Multimorbidity Analysis According to Sex and Age towards Cardiovascular Diseases of Adults in Northeast China

[13] Pattern of Vascular Diseases at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

[14] Understanding the chinese hui ethnic minority’s information seeking on cardiovascular diseases: A focus group study

[15] Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study.

[16] Investigations of the impact of polluted natural waters on cardiovascular diseases and development of integrated prevention system

[17] Implications of Necroptosis for Cardiovascular Diseases.

[18] Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

[19] Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013.

[20] THE USE OF NEURAL NETWORKS FOR THE AUTOMATIC ANALYSIS OF ELECTROCARDIOGRAMS IN DIAGNOSIS OF CARDIOVASCULAR DISEASES

[21] Stress at intellectual work and cardiovascular diseases in women at non-mobility working age.

[22] Community perceptions of dietary and environmental factors as cardiovascular diseases risk determinants.

[23] A-kinase anchoring protein 1 (AKAP1) and its role in some cardiovascular diseases.

[24] Effects of road traffic noise on the prevalence of cardiovascular diseases: The case of Thessaloniki, Greece

[25] Exposure to air pollution and risk of hospitalization for cardiovascular diseases amongst Vietnamese adults: Case-crossover study

[26] A study to evaluate herb-drug interaction underlying mechanisms: An investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases

[27] Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.

[28] The effect of short message system (SMS) reminder on adherence to a healthy diet, medication, and cessation of smoking among adult patients with cardiovascular diseases.

[29] [Research progress on the relationship between circular RNA and cardiovascular diseases].

[30] Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases

[31] COVID-19 in patients with cardiovascular diseases

[32] Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

[33] The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.

[34] study of erythrocyte indices, erythrocyte morphometric indicators, and oxygen-binding properties of hemoglobin hematoporphyrin patients with cardiovascular diseases

[35] atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases

[36] pparδ activity in cardiovascular diseases: a potential pharmacological target

[37] outpatient registry of cardiovascular diseases (recvasa): prospective follow-up data, estimation of risks and outcomes in patients with atrial fibrillation

[38] helicobacter pylori and cardiovascular complications: a mechanism based review on role of helicobacter pylori in cardiovascular diseases

[39] menopausal hormone treatments and risk of cardiovascular diseases: modern view

[40] a study on risk factors of cardiovascular diseases in an urban health center of kolkata

[41] mif and cxcl12 in cardiovascular diseases: functional differences and similarities

[42] the ace gene insertion/deletion polymorphism and cerebrovascular diseases in uzbek patients with arterial hypertension

[43] plaque regression and plaque stabilisation in cardiovascular diseases

[44] platelets are at the nexus of vascular diseases

[45] risk factors of cardiovascular diseases in bushehr port on the basis of the who monica project the persian gulf healthy heart project

[46] impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases

[47] extraskeletal effects of vitamin d: role in the pathogenesis of cardiovascular diseases

[48] endoplasmic reticulum stress-related inflammation and cardiovascular diseases

[49] local anesthetics in patients with cardiovascular diseases.

[50] regulation of ddah1 as a potential therapeutic target for treating cardiovascular diseases

[51] cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities

[52] polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases

[53] predictive factors for cardiovascular diseases in women from the city of jataí, goiás states

[54] stem cell-derived exosome in cardiovascular diseases: macro roles of micro particles

[55] asymptomatic carotid artery stenosis in patients with severe peripheral vascular diseases

[56] salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases

[57] guidelines on diabetes, pre-diabetes, and cardiovascular diseases

[58] beneficial effects of whey protein preloads on some cardiovascular diseases risk factors of overweight and obese men are stronger than soy protein preloads – a randomized clinical trial

[59] the use of calcium channel blockers in the treatment of cardiovascular diseases

[60] periodontitis and cardiovascular diseases: the link and relevant mechanisms

[61] the importance of selected spices in cardiovascular diseases

[62] the prevalence and awareness of cardiovascular diseases risk factors among the lebanese population: a prospective study comparing urban to rural populations

[63] emerging risk biomarkers in cardiovascular diseases and disorders

[64] correlation between anthropometric indexes and risk factors of cardiovascular diseases among the elderly population in amirkola

[65] effect of different glucose blood levels on the development of cardiovascular diseases and complications

[66] dexamethasone- cyclophosphamide pulse in collagen vascular diseases: an observation

[67] the current state of cell therapies for cerebrovascular diseases

[68] microrna-143/-145 in cardiovascular diseases

[69] avaliação da agregação plaquetária e dosagem do fibrinogênio em pacientes com doenças cardiovasculares e sua correlação com o uso de aspirina e fatores de risco coronariano evaluation of platelet aggregation and level of fibrinogen in patients with cardiovascular diseases and the correlation of taking aspirin with coronary risk factors

[70] health innovation in cardiovascular diseases

[71] the porphyromonas gingivalis/host interactome shows enrichment in gwasdb genes related to alzheimer's disease, diabetes and cardiovascular diseases

[72] cardiovascular diseases in china: current status and future perspectives

[73] effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review

[74] incidence of cancers in patients with atherosclerotic cardiovascular diseases

[75] molecular mechanisms explaining the possible effects of phenolic compounds on reducing the risk of cardiovascular diseases

[76] the utilization of nonprescription medications in saudi patients with cardiovascular diseases

[77] functional foods and nutraceuticals in the primary prevention of cardiovascular diseases

[78] a 12- week water aerobic exercise and atorvastatin effect on changes of atrial natriuretic peptide and brain natriuretic peptide in older men with cardiovascular diseases

[79] survey of network-based approaches to research of cardiovascular diseases

[80] quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases

[81] oxidative stress in cardiovascular diseases and obesity: role of p66shc and protein kinase c

[82] role of membrane lipids in the regulation of erythrocytic oxygen-transport function in cardiovascular diseases

[83] streptococcus mutans and cardiovascular diseases

[84] use of n-3 polyunsaturated fatty acids 90% (omacor) for therapy and prevention of cardio-vascular diseases

[85] sex differences in the effect of type 2 diabetes on major cardiovascular diseases: results from a population-based study in italy

[86] cardiovascular diseases: profile of male workers from a distillery in the countryside of sÃo paulo state

[87] school of health for patients with cardio-vascular diseases: balance between andragogic and pedagogic educational models

[88] diverse roles of macrophages in intraocular neovascular diseases: a review

[89] dietary patterns, involvement in physical activity and body mass index of romanian adults having cardio-vascular diseases

[90] suggested indications of clinical practice guideline for stem cell-therapy in cardiovascular diseases: a stepwise appropriate use criteria for regeneration therapy

[91] if channel as an emerging therapeutic target for cardiovascular diseases: a review of current evidence and controversies

[92] identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells

[93] computational and mathematical methods in cardiovascular diseases

[94] Sexual dimorphism in body fat distribution and risk for cardiovascular diseases

[95] Socioeconomic status and trends in risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992

[96] Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach

[97] Prognostic significance of modern markers of severity and development of complications in acute cerebrovascular diseases